Why did Flowers Foods report lower sales in Q2 2026?

Flowers Foods (NYSE:FLO) reported lower sales because Q2 2026 net sales declined 4.0% to $1.193 billion as a 5.8% volume decline offset a 1.8% pricing and mix increase.

What was Flowers Foods’ net income in Q2 2026?

Flowers Foods (NYSE:FLO) reported Q2 2026 net income of $40.7 million, down 30.3% year-over-year, with a net margin of 3.4%.

How did Flowers Foods’ EBITDA change in Q2 2026?

Flowers Foods (NYSE:FLO) reported adjusted EBITDA of $111.3 million in Q2 2026, down 19.2% year-over-year, representing 9.3% of sales.

Why did Flowers Foods reduce its 2026 guidance?

Flowers Foods (NYSE:FLO) reduced its fiscal 2026 guidance after lower sales volume affected expectations for revenue, EBITDA and earnings performance.

Retail

Image for illustrative purposes only. Not a real photo.

Flowers Foods sales fall to $1.19 billion

Written by Brie CarterPublished Aug 20, 2026, 8:20 PM

Flowers Foods (NYSE:FLO) reported Q2 2026 net sales of $1.193 billion, down 4% year-over-year.
Net income declined 30.3% to $40.7 million as volume declines offset pricing gains.
The company lowered its fiscal 2026 sales, EBITDA and earnings guidance ranges.

Flowers Foods (NYSE:FLO) reported second quarter 2026 net sales of $1.193 billion, down 4% year-over-year, as higher pricing and product mix were offset by lower sales volume.

The results compared with the prior-year period as branded retail sales declined 3.8% to $794.6 million and other sales decreased 4.4% to $398.3 million.

Flowers Foods reported net income of $40.7 million, down 30.3% year-over-year, while adjusted EBITDA declined 19.2% to $111.3 million and adjusted diluted earnings per share decreased to $0.21.

The company reported pricing and mix increased 1.8% during the quarter, but volume declined 5.8%, contributing to lower adjusted net income of $44.1 million compared with the prior-year period.

For fiscal 2026, Flowers Foods revised its outlook and now expects net sales of $5.070 billion to $5.142 billion, adjusted EBITDA of $453 million to $481 million, and adjusted diluted earnings per share of $0.75 to $0.85.